医药前沿
醫藥前沿
의약전연
YIAYAO QIANYAN
2015年
15期
10-10,11
,共2页
肖艳琼(综述)%张涛(审校)
肖豔瓊(綜述)%張濤(審校)
초염경(종술)%장도(심교)
结直肠癌肝转移%转化治疗
結直腸癌肝轉移%轉化治療
결직장암간전이%전화치료
Colorectal liver metastases%Conversion therapy%A malignant tumor
结直肠癌是临床常见的恶性肿瘤，60%左右的结直肠癌患者在病程中会出现肝脏转移，结直肠癌肝转移（colorectal cancer liver metastasis，CRLM）是影响预后的主要因素。手术切除是目前治愈 CRLM的唯一方式，但仅有10%～15%的CRLM初始可切除。如何通过临床各手段使初始不可切除的CRLM患者转化为可切除是目前的研究热点。本文就转化治疗的决策及其进展进行综述。
結直腸癌是臨床常見的噁性腫瘤，60%左右的結直腸癌患者在病程中會齣現肝髒轉移，結直腸癌肝轉移（colorectal cancer liver metastasis，CRLM）是影響預後的主要因素。手術切除是目前治愈 CRLM的唯一方式，但僅有10%～15%的CRLM初始可切除。如何通過臨床各手段使初始不可切除的CRLM患者轉化為可切除是目前的研究熱點。本文就轉化治療的決策及其進展進行綜述。
결직장암시림상상견적악성종류，60%좌우적결직장암환자재병정중회출현간장전이，결직장암간전이（colorectal cancer liver metastasis，CRLM）시영향예후적주요인소。수술절제시목전치유 CRLM적유일방식，단부유10%～15%적CRLM초시가절제。여하통과림상각수단사초시불가절제적CRLM환자전화위가절제시목전적연구열점。본문취전화치료적결책급기진전진행종술。
Colorectal cancer is the clinical common malignant tumor, about 60% of patients with colorectal cancer will appear in the course of liver metastasis, liver metastatic colorectal cancer (CRLM) are the main factors influencing the prognosis. At present, surgical resection is the only way to cure CRLM, but only 10% to 15% of CRLM can be resection. How to make through various means, let clinical initial unresectable turn into resectable, is a hot spot in the present study. In this paper, the treatment decision-making and progress were summarized.
